Dermapharm AG
Dermapharm AG, headquartered in Germany, is a prominent player in the pharmaceutical industry, specialising in the development and production of high-quality generic and specialty medications. Founded in 1991, the company has established a strong presence across Europe, with significant operations in various key markets. With a diverse portfolio that includes prescription drugs, over-the-counter products, and active pharmaceutical ingredients, Dermapharm AG is recognised for its commitment to innovation and quality. The company’s unique approach to product development and its focus on niche therapeutic areas set it apart from competitors. Dermapharm AG has achieved notable milestones, including strategic acquisitions that have expanded its market reach and enhanced its product offerings. As a trusted name in the pharmaceutical sector, Dermapharm AG continues to uphold its reputation for excellence and reliability in healthcare solutions.
DitchCarbon Score
How does Dermapharm AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dermapharm AG's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Dermapharm AG's reported carbon emissions
Dermapharm AG, headquartered in Germany, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Dermapharm Holding SE, which may influence its climate-related initiatives and commitments. While Dermapharm AG has not established specific reduction targets or climate pledges, it is important to note that emissions data may be inherited from its parent company, Dermapharm Holding SE. This relationship suggests that any climate commitments or emissions performance may be aligned with the broader strategies of the parent organisation. As of now, Dermapharm AG's climate commitments and reduction initiatives remain unspecified, indicating a potential area for future development in their sustainability efforts. The company may benefit from adopting industry-standard climate terminology and setting measurable targets to enhance its environmental impact and transparency.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dermapharm AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
